Resources

Introduction Since the commercialization of the first therapeutic monoclonal antibody (mAb) in 1986, this class of biopharmaceutical products has grown exponentially. As of November 2014, forty-seven mAb products have been approved in the US or Europe …

Introduction In recent years, the plant‐made pharmaceutical (PMP) community has made significant progress in bringing therapeutics to the clinic: Elelyso™ (Pastores et al., 2014; Zimran et al., 2015) (Protalix, Carmiel, Israel) has been given market …